Project description
Cloud-based solution for pharmaceutical labs
Everything has moved to the cloud, so why not pharmaceutical laboratories. To improve accuracy, process higher workloads and expand test menus, labs today should give up their ‘paper and spreadsheet’ system. It is expensive, inflexible and unsustainable. The EU-funded LeanLab project has a solution: a cloud-based platform that incorporates the latest technologies, including AI, touchscreen technology and visual management tools. The top-selling points include a 45 % reduction in test errors and a 35 % reduction in the amount of time required. The promise of cost savings is attracting customer traction and investor interest. The commercialisation of LeanLab cloud-based solution will ultimately make lifesaving drugs more available to the public.
Objective
Laboratories are under pressure to improve accuracy, process higher workloads and expanding test menus, as well as
become more efficient by reducing costs and using fewer staff. To achieve this, they must significantly improve productivity.
Only currently available solution is consultancy implemented soft ‘paper and spreadsheet’ lean lab system, which is
expensive, inflexible and not sustainable over time; it also cannot address more complex issues such as workload volatility
(dips and peaks, volumes and test mixes) – a key area for achieving productivity savings.
LeanLab cloud-based solution by Plan Domino addresses these issues cheaper, better & sustainably by offering the first
ever digital platform on the market. This important innovation was inspired by absence of alternatives and incorporates latest
technologies, including artificial intelligence (AI). It will have transformative impact on the target customer: 30% productivity
improvement, 45% test error reduction, 25% staff turnover reduction + 35% time reduction, translating into significant costsavings.
This has attracted customer traction and investor interest even at this early stage.
With a revenue model based on a SaaS subscription service and through availability of local strategic partnerships in
international markets, LeanLab is easily scalable and has the potential to achieve a turnover of over €19 million in global
sales, achieve an estimated €11 million in profit and create 112 direct jobs by Year 5 of trading in a market worth over €5
billion by 2022 and a CAGR of 5.1%.
Commercialisation of LeanLab is led by a strong core project team with complementary skills & experience – including firsthand
knowledge of the industry and target market, established relationships with labs in Europe & US. LeanLab project will
enable piloting of the platform at customer sites (to achieve TRL7) and other validation activities to pave way for the next
steps of developing a software version that is market ready.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences artificial intelligence
- natural sciences computer and information sciences software
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- social sciences economics and business economics production economics productivity
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
H91FXR8 GALWAY
Ireland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.